Suppression of the BCL2 family members may trigger disorganization of down/upstream signalling regardless of tumour heterogeneity, though the complex regulatory networks, especially the epigenetic signal and distal regulatory elements, are not well characterized. Here, BCL2 is linked to neoplasm.